| 1 |
30948782 | Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells. | 2019 Apr 4 |
1 |
| 2 |
26416354 | Sensitization of multidrug-resistant human cancer cells to Hsp90 inhibitors by down-regulation of SIRT1. | 2015 Nov 3 |
3 |
| 3 |
22662219 | p53 modulation as a therapeutic strategy in gastrointestinal stromal tumors. | 2012 |
1 |
| 4 |
21478269 | Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells. | 2011 May |
2 |
| 5 |
19956882 | p53 independent radio-sensitization of human lymphoblastoid cell lines by Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin. | 2010 Jan |
1 |
| 6 |
20413784 | Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury. | 2010 Jun 11 |
3 |
| 7 |
20493187 | Geldanamycin and its analog induce cytotoxicity in cultured human retinal pigment epithelial cells. | 2010 Aug |
1 |
| 8 |
18820127 | 90-kDa heat shock protein inhibition abrogates the topoisomerase I poison-induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1. | 2009 Jan |
3 |
| 9 |
17016641 | P53-dependent radiosensitizing effects of Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin on human oral squamous cell carcinoma cell lines. | 2006 Nov |
3 |
| 10 |
17157164 | The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression. | 2006 Dec |
1 |
| 11 |
9622079 | Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations. | 1998 Jun 1 |
2 |